Literature DB >> 15660897

Phacomatosis pigmentokeratotica: a 20-year follow-up with malignant degeneration of both nevus components.

Teresa Martínez-Menchón1, L Mahiques Santos, J J Vilata Corell, I Febrer Bosch, J M Fortea Baixauli.   

Abstract

Phacomatosis pigmentokeratotica is a rare syndrome defined by the association of an organoid nevus occasionally with sebaceous differentiation, a speckled lentiginous nevus, and other extracutaneous anomalies. The disorder is a consequence of the so-called twin spot genetic mechanism. We describe the first occurrence involving malignant degeneration of both nevus components, giving rise to three basal cell carcinomas over the sebaceous nevus and a malignant melanoma of the superficial spreading type over the speckled lentiginous nevus. This observation, in concert with the other instances reported in the literature, points to the need for adequate patient follow-up to ensure early detection and treatment of any possible associated malignant degeneration.

Entities:  

Mesh:

Year:  2005        PMID: 15660897     DOI: 10.1111/j.1525-1470.2005.22110.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  3 in total

1.  Phacomatosis pigmentokeratotica without extracutaneous abnormalities: a case study involving a preterm baby.

Authors:  Ga Na Oh; Jong Yeob Kim; Jae Eun Choi; Hyo Hyun Ahn; Young Chul Kye; Soo Hong Seo
Journal:  J Korean Med Sci       Date:  2012-10-30       Impact factor: 2.153

2.  Combined melanocytic and sweat gland neoplasm: cell subsets harbor an identical HRAS mutation in phacomatosis pigmentokeratotica.

Authors:  Janet Y Li; Michael F Berger; Ashfaq Marghoob; Umesh K Bhanot; Jennifer P Toyohara; Melissa P Pulitzer
Journal:  J Cutan Pathol       Date:  2014-07-09       Impact factor: 1.587

3.  Phacomatosis pigmentokeratotica without extracutaneous abnormalities: 12-year follow-up.

Authors:  Claire E Hannah; Jaclyn R Keller; Megan H Noe; Jennifer R S Gordon; Emily K Fridlington; Roger I Ceilley; Vincent Liu
Journal:  JAAD Case Rep       Date:  2019-11-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.